<DOC>
	<DOC>NCT01277211</DOC>
	<brief_summary>This is a study to assess the effectiveness of NuvaRing® (SCH 900702) for the prevention of pregnancy in fertile Chinese women. The acceptability and safety of NuvaRing® will also be assessed and compared with that of Yasmin.</brief_summary>
	<brief_title>A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)</brief_title>
	<detailed_description>The purpose of this study is to assess the contraceptive efficacy of NuvaRing in fertile Chinese women; to assess vaginal bleeding pattern (cycle control), general safety, and acceptability of NuvaRing; and to evaluate the NuvaRing's effect on dysmenorrhea.</detailed_description>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<criteria>Key Sexually active Chinese women, at risk for pregnancy and not planning to use condoms during trial medication use Women in need for contraception and willing to use a hormonal contraceptive method for 13 cycles Body mass index ≥18 and ≤29 kg/m^2 Key Contraindications for contraceptive steroids Abnormal cervical smear corresponding to indeterminate changes at screening Clinically relevant abnormal laboratory result at screening as judged by the investigator.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Contraception</keyword>
	<keyword>NuvaRing</keyword>
</DOC>